Health

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) is a challenging condition to diagnose due to its rarity and heterogeneity. Dr. Jeffrey Allen from the University of Minnesota emphasized the critical need for valid biomarkers in CIDP to improve diagnosis and understand disease activity. The current standard treatments for CIDP, including intravenous immunoglobulin (IVIG), steroids, and plasma exchange,
0 Comments
The Food and Drug Administration (FDA) recently issued a warning to Akan Biosciences, a Maryland-based company, regarding their allogenic, adipose-derived stromal vascular fraction (SVF) product, known as Ayama. This warning highlighted the fact that the product must be regulated as a drug and a biologic, as opposed to the more lenient category it was previously
0 Comments
The recent statement by the CDC regarding the potential increased risk of the H5N1 virus to human health has sparked concerns about a possible pandemic. While the current risk remains low, the agency is gearing up for the possibility that the influenza A(H5N1) viruses could mutate and become easily transmissible among humans, leading to a
0 Comments